APA (7th ed.) Citation

Romani, L., Oikonomou, V., Moretti, S., Iannitti, R. G., D'Adamo, M. C., Villella, V. R., . . . Garaci, E. (2017). Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis. Nature Medicine, 23(5), 590-600. https://doi.org/10.1038/nm.4305

Chicago Style (17th ed.) Citation

Romani, Luigina, et al. "Thymosin α1 Represents a Potential Potent Single-molecule-based Therapy for Cystic Fibrosis." Nature Medicine 23, no. 5 (2017): 590-600. https://doi.org/10.1038/nm.4305.

MLA (9th ed.) Citation

Romani, Luigina, et al. "Thymosin α1 Represents a Potential Potent Single-molecule-based Therapy for Cystic Fibrosis." Nature Medicine, vol. 23, no. 5, 2017, pp. 590-600, https://doi.org/10.1038/nm.4305.